Incyte (INCY) News
NASDAQ: INCYHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
112.79+0.04 (+0.04%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
INCY news summary
We found 3 recent headlines mentioning Incyte (INCY): 1 in the past week and 3 in the past 30 days, most often from Nasdaq, Business Wire. For price context, INCY is up 0.04% at $112.79. The most recent story, "Incyte to Report Third Quarter Financial Results", was published by Business Wire on Oct 8, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Incyte headlines
- Incyte to Report Third Quarter Financial ResultsWILMINGTON, Del.--(BUSINESS WIRE)--3Q26 Earnings AnnouncementBusiness Wire
- Weekly Buzz: EW, ABBV, MIRM Score FDA Wins, AZN, NVO Strike Deals; LLY, KOD Report Data(RTTNews) - The week brought a fresh round of developments across the biotech and pharma landscape, with companies advancing new therapies through regulatory milestones, clinical studies, strategic…NasdaqABBV, AZN, CBLL, CDXS
- INCY Stock Gains 23% Year to Date: Buy, Sell or Hold?Incyte's strong product demand and pipeline progress fuel its 23% YTD rally, but valuation and near-term earnings pressure temper the outlook.NasdaqINCY, GSK, NVS